Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 16-substituted-4-aza-androstane 5-.alpha.-reductase isozyme 1 inhibitors

16-substituted-4-aza-androstane 5-.alpha.-reductase isozyme 1 inhibitors

US Patent 6204273 · Granted Mar 20, 2001

Estimated economic value: $188,200,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antidiabetic tricyclic compounds2018
Antidiabetic tricyclic compounds2018
Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitors2017
Antidiabetic bicyclic compounds2017
Antidiabetic substituted heteroaryl compounds2017
Metallo-beta-lactamase inhibitors2017
Oligonucleotide conjugates2017
Antidiabetic tricyclic compounds2016
Tris(hydroxymethyl)aminomethane salts of a small-molecule GLP1R agonist and phar2015
Oligonucleotide conjugates2015
Oxadiazole beta carboline derivatives as antidiabetic compounds2014
P38 kinase inhibiting agents2013